2023-508797-28-00CompletedPhase 1
The Attractive 2 trial – An open-label, randomised, 2-period cross-over trial to assess the pharmacokinetics of ATR-258 oral capsule vs. oral solution formulations in healthy volunteers
Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Feb 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- First submitted
- 16 Nov 2023
- Start date
- 24 Apr 2024
- Lead sponsor
- Atrogi AB
- EU CT number
- 2023-508797-28-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 12
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CTC Clinical Trial Consultants AB | Uppsala | Sweden | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.